Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
© 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4·0 license Background: The emergence and spread of resistance in Plasmodium falciparum malaria to artemisinin combination therapies in the Greater Mekong subregion poses a major threat to malaria c...
Saved in:
Similar Items
-
Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study
by: Roberto Amato, et al.
Published: (2019) -
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
by: Rob W. van der Pluijm, et al.
Published: (2020) -
Ex Vivo Susceptibility of Plasmodium falciparum to antimalarial drugs in western, Northern, and Eastern Cambodia, 2011-2012: Association with molecular markers
by: Pharath Lim, et al.
Published: (2018) -
Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum
by: Megan R. Ansbro, et al.
Published: (2020) -
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: A parasite clearance rate study
by: Chanaki Amaratunga, et al.
Published: (2018)